TLR2 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with TLR2 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with TLR2 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with TLR2 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with TLR2 Up.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000204539 - corneodesmosin

Gene

ENSG00000006118 - transmembrane protein 132A

Gene

ENSG00000143536 - cornulin

Gene

ENSG00000126934 - mitogen-activated protein kinase kinase 2

Gene

ENSG00000164081 - testis expressed 264, ER-phagy receptor

Gene

ENSG00000176783 - RUN and FYVE domain containing 1

Gene

ENSG00000163207 - involucrin

Gene

ENSG00000090097 - poly(rC) binding protein 4

Gene

ENSG00000005001 - serine protease 22

Gene

ENSG00000010322 - nischarin

  • Gene

    ENSG00000204539 - corneodesmosin


  • Gene

    ENSG00000006118 - transmembrane protein 132A


  • Gene

    ENSG00000143536 - cornulin


  • Gene

    ENSG00000126934 - mitogen-activated protein kinase kinase 2


  • Gene

    ENSG00000164081 - testis expressed 264, ER-phagy receptor


  • Gene

    ENSG00000176783 - RUN and FYVE domain containing 1


  • Gene

    ENSG00000163207 - involucrin


  • Gene

    ENSG00000090097 - poly(rC) binding protein 4


  • Gene

    ENSG00000005001 - serine protease 22


  • Gene

    ENSG00000010322 - nischarin

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.